Novel sulfonamide derivatives as multitarget antidiabetic agents: design, synthesis, and biological evaluation. 2024

Mohammed Salah Ayoup, and Nourhan Khaled, and Hamida Abdel-Hamid, and Doaa A Ghareeb, and Samah A Nasr, and Ahmed Omer, and Amr Sonousi, and Asmaa E Kassab, and Abdelazeem S Eltaweil
Department of Chemistry, Faculty of Science, Alexandria University Alexandria Egypt mayoup@kfu.edu.sa mohammedsalahayoup@gmail.com.

A series of new sulfonamide derivatives connected through an imine linker to five or seven membered heterocycles were designed and synthesized. All synthesized derivatives were characterized using a variety of spectroscopic methods, including IR, 1HNMR, and 13CNMR. In vitro α-glucosidase and α-amylase inhibition activities, as well as glucose uptake were assessed for each of the synthesized compounds. Four sulfonamide derivatives namely 3a, 3b, 3h and 6 showed excellent inhibitory potential against α-glucosidase with IC50 values of 19.39, 25.12, 25.57 and 22.02 μM, respectively. They were 1.05- to 1.39-fold more potent than acarbose. Sulfonamide derivatives 3g, 3i and 7 (EC50 values of 1.29, 21.38 and 19.03 μM, respectively) exhibited significant glucose uptake activity that were 1.62- to 27-fold more potent than berberine. Both α-glucosidase protein (PDB: 2QMJ) and α-amylase (PDB: 1XCW) complexed with acarbose were adopted for docking investigations for the most active synthesized compounds. The docked compounds were able to inhabit the same space as the acarviosin ring of acarbose. The docking of the most active compounds showed an analogous binding with the active site of α-glucosidase as acarbose. The superior activity of the synthesized compounds against α-glucosidase enzyme than α-amylase enzyme can be rationalized by the weak interaction with the α-amylase. The physiochemical parameters of all synthesized compounds were aligned with Lipinski's rule of five.

UI MeSH Term Description Entries

Related Publications

Mohammed Salah Ayoup, and Nourhan Khaled, and Hamida Abdel-Hamid, and Doaa A Ghareeb, and Samah A Nasr, and Ahmed Omer, and Amr Sonousi, and Asmaa E Kassab, and Abdelazeem S Eltaweil
November 2020, Bioorganic chemistry,
Mohammed Salah Ayoup, and Nourhan Khaled, and Hamida Abdel-Hamid, and Doaa A Ghareeb, and Samah A Nasr, and Ahmed Omer, and Amr Sonousi, and Asmaa E Kassab, and Abdelazeem S Eltaweil
October 2022, Molecules (Basel, Switzerland),
Mohammed Salah Ayoup, and Nourhan Khaled, and Hamida Abdel-Hamid, and Doaa A Ghareeb, and Samah A Nasr, and Ahmed Omer, and Amr Sonousi, and Asmaa E Kassab, and Abdelazeem S Eltaweil
September 2022, Drug development research,
Mohammed Salah Ayoup, and Nourhan Khaled, and Hamida Abdel-Hamid, and Doaa A Ghareeb, and Samah A Nasr, and Ahmed Omer, and Amr Sonousi, and Asmaa E Kassab, and Abdelazeem S Eltaweil
August 2019, Archiv der Pharmazie,
Mohammed Salah Ayoup, and Nourhan Khaled, and Hamida Abdel-Hamid, and Doaa A Ghareeb, and Samah A Nasr, and Ahmed Omer, and Amr Sonousi, and Asmaa E Kassab, and Abdelazeem S Eltaweil
April 2023, ACS omega,
Mohammed Salah Ayoup, and Nourhan Khaled, and Hamida Abdel-Hamid, and Doaa A Ghareeb, and Samah A Nasr, and Ahmed Omer, and Amr Sonousi, and Asmaa E Kassab, and Abdelazeem S Eltaweil
July 2017, European journal of medicinal chemistry,
Mohammed Salah Ayoup, and Nourhan Khaled, and Hamida Abdel-Hamid, and Doaa A Ghareeb, and Samah A Nasr, and Ahmed Omer, and Amr Sonousi, and Asmaa E Kassab, and Abdelazeem S Eltaweil
May 2017, Acta poloniae pharmaceutica,
Mohammed Salah Ayoup, and Nourhan Khaled, and Hamida Abdel-Hamid, and Doaa A Ghareeb, and Samah A Nasr, and Ahmed Omer, and Amr Sonousi, and Asmaa E Kassab, and Abdelazeem S Eltaweil
January 2018, Chemical & pharmaceutical bulletin,
Mohammed Salah Ayoup, and Nourhan Khaled, and Hamida Abdel-Hamid, and Doaa A Ghareeb, and Samah A Nasr, and Ahmed Omer, and Amr Sonousi, and Asmaa E Kassab, and Abdelazeem S Eltaweil
October 2021, Bioorganic chemistry,
Mohammed Salah Ayoup, and Nourhan Khaled, and Hamida Abdel-Hamid, and Doaa A Ghareeb, and Samah A Nasr, and Ahmed Omer, and Amr Sonousi, and Asmaa E Kassab, and Abdelazeem S Eltaweil
January 2015, European journal of medicinal chemistry,
Copied contents to your clipboard!